In the third quarter of 2024, Medicalgorithmics focused on increasing service sales and acquiring new clients, in line with its strategic plan. During this...
Algorithms of the artificial intelligence DeepRhythmAI (DRAI), used for automatic ECG data analysis, have received extended FDA registration in the USA. With the updated...
Artificial intelligence algorithms DeepRhythmAI (DRAI), used for ECG data analysis, have obtained Health Canada registration for use in Canada. This is another regulatory approval...
In the first half of 2024, Medicalgorithmics, a technology company from the sWIG80 index, has successfully continued to acquire new customers, focusing on the...
Medicalgorithmics, a technology company part of the sWIG80 index, has signed an agreement with American Heart of Poland, the operator of the Polish-American Heart...
Medicalgorithmics has signed a collaboration agreement to conduct a clinical study on the detection of atrial fibrillation following non-cardiac surgeries. The company's technological solutions,...